创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: Introducing the Benefits of In Situ Surgical Models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-08 10:02
  • Views:

(Summary description)In the journey of neuroscience, the deep understanding and effective treatment of brain diseases have been greatly challenged. As technology continues to advance, Biologically Accurate Surgical Models (BASM) have emerged to provide an unprecedented way to study the physiological and pathological processes of the brain, opening up new avenues for disease treatment. Below is a detailed description of the advantages of the InnoModels Biotechnology Accurate Surgical Models

InnoModels: Introducing the Benefits of In Situ Surgical Models

(Summary description)In the journey of neuroscience, the deep understanding and effective treatment of brain diseases have been greatly challenged. As technology continues to advance, Biologically Accurate Surgical Models (BASM) have emerged to provide an unprecedented way to study the physiological and pathological processes of the brain, opening up new avenues for disease treatment. Below is a detailed description of the advantages of the InnoModels Biotechnology Accurate Surgical Models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-08 10:02
  • Views:
Information

In the journey of neuroscience, the deep understanding and effective treatment of brain diseases have been greatly challenged. As technology continues to advance, Biologically Accurate Surgical Models (BASM) have emerged to provide an unprecedented way to study the physiological and pathological processes of the brain, opening up new avenues for disease treatment. Below is a detailed description of the advantages of the InnoModels Biotechnology Accurate Surgical Models.
Highly Simulated Surgical Environment
One of the greatest advantages of the InnoModels Bio-In-Situ Surgical Model is its ability to simulate real surgical operations in a highly realistic environment. This model uses advanced biomaterials and technology to accurately replicate the anatomical structure and physiological functions of the brain, thus allowing researchers to perform a variety of delicate operations, such as tissue removal and vascular suturing, during simulated surgical procedures.
Real-time physiological feedback
Unlike traditional static models, the InnoModels Bio-In-Situ Surgical Model is able to provide real-time physiological feedback. This means that during simulated surgery, the model is able to mimic real brain responses such as bleeding, swelling and inflammatory responses. This real-time feedback allows researchers to more realistically assess surgical outcomes and risks to optimize surgical protocols.

 


Reduced experimental risk
Due to the high degree of simulation of the InnoModels Bioin situ surgical model, researchers can perform multiple surgical exercises and simulations on the model without the need to conduct experiments on real patients. This greatly reduces experimental risks and unnecessary injuries to patients, as well as providing valuable practice opportunities for physicians.
Facilitating drug development and therapeutic innovation
InnoModels' biologic in situ surgical models provide a powerful platform for drug discovery and therapeutic innovation. By simulating different disease states and surgical procedures, researchers can test the effects of different drugs and treatments to screen for the most effective treatment options. This provides strong support for therapeutic advances in neuroscience.
Promoting international cooperation and exchange
The standardization and reproducibility of the InnoModels Bioin situ surgical model makes international collaboration and exchange easier. Researchers from different countries and regions can conduct experiments using the same model, thus comparing and validating their respective research results. This helps to promote the overall progress and development of the field of neuroscience.
Wide Application Prospects
The InnoModels Bioin situ Surgical Model has a wide range of application prospects. It can be used not only to study the surgical treatment of neurological diseases such as tumors, vascular lesions, epilepsy, etc., but also to study the surgical intervention strategies for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. In addition, with the continuous advancement of technology, this model is expected to play an important role in the fields of neuroregenerative medicine and neuroengineering.
In conclusion, the in-situ surgical model of InnoModels Biotechnology has become a major breakthrough in the field of neuroscience research due to its advantages of high simulation, real-time physiological feedback, reduction of experimental risk, facilitation of drug development and therapeutic innovation, as well as a wide range of application prospects. With the continuous development and improvement of this technology, we have reason to believe that it will play an even more important role in future neuroscience research.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司